This document is a Form 10-Q Quarterly Report filed by WEST PHARMACEUTICAL SERVICES, INC. with the United States Securities and Exchange Commission (SEC) for the period ending June 30, 2025. It provides unaudited condensed consolidated financial statements, including statements of income, comprehensive income, balance sheets, and cash flows, for the company and its subsidiaries. The report also includes management's discussion and analysis of financial condition and results of operations, detailing performance across its Proprietary Products and Contract-Manufactured Products segments, and discussing market risks, legal proceedings, and changes in internal controls.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related